Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS.

Edwards DJ, Cortes M, Rykman-Peltz A, Chang J, Elder J, Thickbroom G, Mariman JJ, Gerber LM, Oromendia C, Krebs HI, Fregni F, Volpe BT, Pascual-Leone A.

Restor Neurol Neurosci. 2019;37(2):167-180. doi: 10.3233/RNN-180869.

PMID:
30932903
2.

Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Mackay M, Vo A, Tang CC, Small M, Anderson EW, Ploran EJ, Storbeck J, Bascetta B, Kang S, Aranow C, Sartori C, Watson P, Volpe BT, Diamond B, Eidelberg D.

JCI Insight. 2019 Jan 10;4(1). pii: 124002. doi: 10.1172/jci.insight.124002. [Epub ahead of print]

3.

Robotic Arm Rehabilitation in Chronic Stroke Patients With Aphasia May Promote Speech and Language Recovery (but Effect Is Not Enhanced by Supplementary tDCS).

Buchwald A, Falconer C, Rykman-Peltz A, Cortes M, Pascual-Leone A, Thickbroom GW, Krebs HI, Fregni F, Gerber LM, Oromendia C, Chang J, Volpe BT, Edwards DJ.

Front Neurol. 2018 Oct 22;9:853. doi: 10.3389/fneur.2018.00853. eCollection 2018.

4.

Constitutive Vagus Nerve Activation Modulates Immune Suppression in Sepsis Survivors.

Rana M, Fei-Bloom Y, Son M, La Bella A, Ochani M, Levine YA, Chiu PY, Wang P, Chavan SS, Volpe BT, Sherry B, Diamond B.

Front Immunol. 2018 Sep 6;9:2032. doi: 10.3389/fimmu.2018.02032. eCollection 2018.

5.

Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors.

Nestor J, Arinuma Y, Huerta TS, Kowal C, Nasiri E, Kello N, Fujieda Y, Bialas A, Hammond T, Sriram U, Stevens B, Huerta PT, Volpe BT, Diamond B.

J Exp Med. 2018 Oct 1;215(10):2554-2566. doi: 10.1084/jem.20180776. Epub 2018 Sep 5.

6.

Editorial.

Volpe BT.

Curr Opin Neurol. 2018 Jun;31(3):291-293. doi: 10.1097/WCO.0000000000000555. No abstract available.

PMID:
29547403
7.

Fletcher H. McDowell 1923-2017.

Volpe BT.

Stroke. 2017 Sep;48(9):2335-2336. doi: 10.1161/STROKEAHA.117.018798. Epub 2017 Aug 3. No abstract available.

PMID:
28775138
8.

Fletcher H. McDowell, MD, 1923-2017.

Cedarbaum JM, Aisen M, Volpe BT.

Ann Neurol. 2017 Jul;82(1):1-3. doi: 10.1002/ana.24959. Epub 2017 Jul 10. No abstract available.

PMID:
28544007
9.

Intensive seated robotic training of the ankle in patients with chronic stroke differentially improves gait.

Chang JL, Lin RY, Saul M, Koch PJ, Krebs HI, Volpe BT.

NeuroRehabilitation. 2017;41(1):61-68. doi: 10.3233/NRE-171457.

PMID:
28505988
10.

Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.

Son M, Diamond B, Volpe BT, Aranow CB, Mackay MC, Santiago-Schwarz F.

Sci Rep. 2017 Mar 21;7(1):270. doi: 10.1038/s41598-017-00290-w.

11.

Preclinical models of overwhelming sepsis implicate the neural system that encodes contextual fear memory.

Huerta PT, Robbiati S, Huerta TS, Sabharwal A, Berlin RA, Frankfurt M, Volpe BT.

Mol Med. 2016 Dec;22:789-799. doi: 10.2119/molmed.2015.00201. Epub 2016 Nov 17.

12.

C1q and HMGB1 reciprocally regulate human macrophage polarization.

Son M, Porat A, He M, Suurmond J, Santiago-Schwarz F, Andersson U, Coleman TR, Volpe BT, Tracey KJ, Al-Abed Y, Diamond B.

Blood. 2016 Nov 3;128(18):2218-2228. Epub 2016 Sep 28.

13.

Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice.

Brimberg L, Mader S, Jeganathan V, Berlin R, Coleman TR, Gregersen PK, Huerta PT, Volpe BT, Diamond B.

Mol Psychiatry. 2016 Dec;21(12):1663-1671. doi: 10.1038/mp.2016.165. Epub 2016 Oct 4.

14.

Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies.

VanPatten S, Sun S, He M, Cheng KF, Altiti A, Papatheodorou A, Kowal C, Jeganathan V, Crawford JM, Bloom O, Volpe BT, Grant C, Meurice N, Coleman TR, Diamond B, Al-Abed Y.

J Med Chem. 2016 Oct 13;59(19):8859-8867. Epub 2016 Sep 20.

15.

Robotics: A Rehabilitation Modality.

Krebs HI, Volpe BT.

Curr Phys Med Rehabil Rep. 2015 Dec;3(4):243-147. Epub 2015 Oct 13. No abstract available.

16.

Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve.

Honig G, Mader S, Chen H, Porat A, Ochani M, Wang P, Volpe BT, Diamond B.

PLoS One. 2016 Jan 20;11(1):e0144215. doi: 10.1371/journal.pone.0144215. eCollection 2016.

17.

HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors.

Valdés-Ferrer SI, Papoin J, Dancho ME, Olofsson PS, Li J, Lipton JM, Avancena P, Yang H, Zou YR, Chavan SS, Volpe BT, Gardenghi S, Rivella S, Diamond B, Andersson U, Steinberg BM, Blanc L, Tracey KJ.

Mol Med. 2016 May;21(1):951-958. doi: 10.2119/molmed.2015.00243. Epub 2015 Dec 29.

18.

Antibodies as Mediators of Brain Pathology.

Brimberg L, Mader S, Fujieda Y, Arinuma Y, Kowal C, Volpe BT, Diamond B.

Trends Immunol. 2015 Nov;36(11):709-724. doi: 10.1016/j.it.2015.09.008. Epub 2015 Oct 19. Review.

19.

The brain at risk: the sepsis syndrome and lessons from preclinical experiments.

Volpe BT, Berlin RA, Frankfurt M.

Immunol Res. 2015 Dec;63(1-3):70-4. doi: 10.1007/s12026-015-8704-7.

20.

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.

Chang EH, Volpe BT, Mackay M, Aranow C, Watson P, Kowal C, Storbeck J, Mattis P, Berlin R, Chen H, Mader S, Huerta TS, Huerta PT, Diamond B.

EBioMedicine. 2015 May 30;2(7):755-64. doi: 10.1016/j.ebiom.2015.05.027. eCollection 2015 Jul.

21.

Stroke subtype and motor impairment influence contralesional excitability.

Thickbroom GW, Cortes M, Rykman A, Volpe BT, Fregni F, Krebs HI, Pascual-Leone A, Edwards DJ.

Neurology. 2015 Aug 11;85(6):517-20. doi: 10.1212/WNL.0000000000001828. Epub 2015 Jul 17.

22.

Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.

Mackay M, Tang CC, Volpe BT, Aranow C, Mattis PJ, Korff RA, Diamond B, Eidelberg D.

Lupus Sci Med. 2015 Mar 28;2(1):e000074. doi: 10.1136/lupus-2014-000074. eCollection 2015.

23.

The gut microbiota influences blood-brain barrier permeability in mice.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S.

Sci Transl Med. 2014 Nov 19;6(263):263ra158. doi: 10.1126/scitranslmed.3009759. Erratum in: Sci Transl Med. 2014 Dec 10;6(266):266er7. Guan, Ng Lai [corrected to Ng, Lai Guan].

24.

Reply: evidence against volume conduction to explain normal MEPs in muscles with low motor power in SCI.

Edwards DJ, Cortes M, Thickbroom GW, Rykman A, Pascual-Leone A, Volpe BT.

Spinal Cord. 2014 Sep;52(9):718. doi: 10.1038/sc.2014.117. Epub 2014 Jul 22. No abstract available.

25.

Regional brain metabolism in a murine systemic lupus erythematosus model.

Vo A, Volpe BT, Tang CC, Schiffer WK, Kowal C, Huerta PT, Uluğ AM, Dewey SL, Eidelberg D, Diamond B.

J Cereb Blood Flow Metab. 2014 Aug;34(8):1315-20. doi: 10.1038/jcbfm.2014.85. Epub 2014 May 14.

26.

Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery.

Krebs HI, Krams M, Agrafiotis DK, DiBernardo A, Chavez JC, Littman GS, Yang E, Byttebier G, Dipietro L, Rykman A, McArthur K, Hajjar K, Lees KR, Volpe BT.

Stroke. 2014 Jan;45(1):200-4. doi: 10.1161/STROKEAHA.113.002296. Epub 2013 Dec 12.

27.

Transcranial direct current stimulation (tDCS) and robotic practice in chronic stroke: the dimension of timing.

Giacobbe V, Krebs HI, Volpe BT, Pascual-Leone A, Rykman A, Zeiarati G, Fregni F, Dipietro L, Thickbroom GW, Edwards DJ.

NeuroRehabilitation. 2013;33(1):49-56. doi: 10.3233/NRE-130927.

28.

Pilot study of a robotic protocol to treat shoulder subluxation in patients with chronic stroke.

Dohle CI, Rykman A, Chang J, Volpe BT.

J Neuroeng Rehabil. 2013 Aug 5;10:88. doi: 10.1186/1743-0003-10-88.

29.

Preserved corticospinal conduction without voluntary movement after spinal cord injury.

Edwards DJ, Cortes M, Thickbroom GW, Rykman A, Pascual-Leone A, Volpe BT.

Spinal Cord. 2013 Oct;51(10):765-7. doi: 10.1038/sc.2013.74. Epub 2013 Jul 30.

30.

Brain-reactive antibodies and disease.

Diamond B, Honig G, Mader S, Brimberg L, Volpe BT.

Annu Rev Immunol. 2013;31:345-85. doi: 10.1146/annurev-immunol-020711-075041. Review.

31.

Rehabilitation robotics.

Krebs HI, Volpe BT.

Handb Clin Neurol. 2013;110:283-94. doi: 10.1016/B978-0-444-52901-5.00023-X. Review.

32.

A model for lupus brain disease.

Diamond B, Volpe BT.

Immunol Rev. 2012 Jul;248(1):56-67. doi: 10.1111/j.1600-065X.2012.01137.x. Review.

33.

HMGB1 mediates cognitive impairment in sepsis survivors.

Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, Frankfurt M, Volpe BT, Tracey KJ, Diamond B.

Mol Med. 2012 Sep 7;18:930-7. doi: 10.2119/molmed.2012.00195.

34.

Female mouse fetal loss mediated by maternal autoantibody.

Wang L, Zhou D, Lee J, Niu H, Faust TW, Frattini S, Kowal C, Huerta PT, Volpe BT, Diamond B.

J Exp Med. 2012 Jun 4;209(6):1083-9. doi: 10.1084/jem.20111986. Epub 2012 May 7.

35.

Predicting efficacy of robot-aided rehabilitation in chronic stroke patients using an MRI-compatible robotic device.

Sergi F, Krebs HI, Groissier B, Rykman A, Guglielmelli E, Volpe BT, Schaechter JD.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7470-3. doi: 10.1109/IEMBS.2011.6091843.

36.

Learning, not adaptation, characterizes stroke motor recovery: evidence from kinematic changes induced by robot-assisted therapy in trained and untrained task in the same workspace.

Dipietro L, Krebs HI, Volpe BT, Stein J, Bever C, Mernoff ST, Fasoli SE, Hogan N.

IEEE Trans Neural Syst Rehabil Eng. 2012 Jan;20(1):48-57. doi: 10.1109/TNSRE.2011.2175008. Epub 2011 Dec 16.

37.

Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration.

Mackay M, Bussa MP, Aranow C, Uluğ AM, Volpe BT, Huerta PT, Argyelan M, Mandel A, Hirsch J, Diamond B, Eidelberg D.

Mol Med. 2011;17(11-12):1349-56. doi: 10.2119/molmed.2011.00185. Epub 2011 Sep 21.

38.

Reversal of TMS-induced motor twitch by training is associated with a reduction in excitability of the antagonist muscle.

Giacobbe V, Volpe BT, Thickbroom GW, Fregni F, Pascual-Leone A, Krebs HI, Edwards DJ.

J Neuroeng Rehabil. 2011 Aug 24;8:46. doi: 10.1186/1743-0003-8-46.

39.

An economic analysis of robot-assisted therapy for long-term upper-limb impairment after stroke.

Wagner TH, Lo AC, Peduzzi P, Bravata DM, Huang GD, Krebs HI, Ringer RJ, Federman DG, Richards LG, Haselkorn JK, Wittenberg GF, Volpe BT, Bever CT, Duncan PW, Siroka A, Guarino PD.

Stroke. 2011 Sep;42(9):2630-2. doi: 10.1161/STROKEAHA.110.606442. Epub 2011 Jul 14.

40.
41.

Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

Bloom O, Cheng KF, He M, Papatheodorou A, Volpe BT, Diamond B, Al-Abed Y.

Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10255-9. doi: 10.1073/pnas.1103555108. Epub 2011 Jun 6. Erratum in: Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18566. Cheng, Kai Fen [corrected to Cheng, Kai Fan].

42.

Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

Wang YH, Yan Y, Rice JS, Volpe BT, Diamond B.

J Autoimmun. 2011 Aug;37(1):18-27. doi: 10.1016/j.jaut.2011.03.002. Epub 2011 Apr 1.

43.

Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.

Diamond B, Bloom O, Al Abed Y, Kowal C, Huerta PT, Volpe BT.

J Intern Med. 2011 Jan;269(1):36-44. doi: 10.1111/j.1365-2796.2010.02318.x. Review.

44.

Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, Zhang J, Sanchez-Guerrero J, Fragoso-Loyo HE, Volpe BT, Diamond B, Huerta PT.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18569-74. doi: 10.1073/pnas.1006980107. Epub 2010 Oct 4.

45.

Robot-assisted therapy for long-term upper-limb impairment after stroke.

Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, Ringer RJ, Wagner TH, Krebs HI, Volpe BT, Bever CT Jr, Bravata DM, Duncan PW, Corn BH, Maffucci AD, Nadeau SE, Conroy SS, Powell JM, Huang GD, Peduzzi P.

N Engl J Med. 2010 May 13;362(19):1772-83. doi: 10.1056/NEJMoa0911341. Epub 2010 Apr 16. Erratum in: N Engl J Med. 2011 Nov 3;365(18):1749.

46.

Robotic devices as therapeutic and diagnostic tools for stroke recovery.

Volpe BT, Huerta PT, Zipse JL, Rykman A, Edwards D, Dipietro L, Hogan N, Krebs HI.

Arch Neurol. 2009 Sep;66(9):1086-90. doi: 10.1001/archneurol.2009.182. Review.

47.

XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development.

Todd DJ, McHeyzer-Williams LJ, Kowal C, Lee AH, Volpe BT, Diamond B, McHeyzer-Williams MG, Glimcher LH.

J Exp Med. 2009 Sep 28;206(10):2151-9. doi: 10.1084/jem.20090738. Epub 2009 Sep 14.

48.

Multicenter randomized trial of robot-assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICS.

Lo AC, Guarino P, Krebs HI, Volpe BT, Bever CT, Duncan PW, Ringer RJ, Wagner TH, Richards LG, Bravata DM, Haselkorn JK, Wittenberg GF, Federman DG, Corn BH, Maffucci AD, Peduzzi P.

Neurorehabil Neural Repair. 2009 Oct;23(8):775-83. doi: 10.1177/1545968309338195. Epub 2009 Jun 18.

49.

Raised corticomotor excitability of M1 forearm area following anodal tDCS is sustained during robotic wrist therapy in chronic stroke.

Edwards DJ, Krebs HI, Rykman A, Zipse J, Thickbroom GW, Mastaglia FL, Pascual-Leone A, Volpe BT.

Restor Neurol Neurosci. 2009;27(3):199-207. doi: 10.3233/RNN-2009-0470.

50.

Losing your nerves? Maybe it's the antibodies.

Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT.

Nat Rev Immunol. 2009 Jun;9(6):449-56. doi: 10.1038/nri2529. Review.

Supplemental Content

Loading ...
Support Center